Last reviewed · How we verify

NCT04454333

COVID-19 in Pain Perspective

Completed Last updated 1 July 2020
What this trial tests

trial in Infection in 466 participants. Completed in 20 June 2020.

Timeline
3 June 2020
Primary endpoint
18 June 2020
20 June 2020

Quick facts

Lead sponsorSisli Hamidiye Etfal Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment466
Start date3 June 2020
Primary completion18 June 2020
Estimated completion20 June 2020
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

Adults 18 to 95, any sex, with Infection or COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In our hospital's Infectious Diseases and Clinical Microbiology service, patients who have been hospitalized due to Covid -19 infection have a musculoskeletal pain and headache during this process, and 466 patients will be recruited to compare them with the pre-disease state of the patients and to evaluate the pain status of the patients after treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation and follow-up of pain, fatigue, and quality of life in COVID-19 patients.
    Adar S, Konya PŞ, Akçin Aİ, Dündar Ü, et al · · 2023 · cited 4× · PMID 36944344 · DOI 10.24171/j.phrp.2022.0275

Verify or expand the search:

Other recruiting trials for Infection

Currently open trials in the same condition.

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04454333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing